We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
3 result(s) found, displaying 1 to 3
-
Australian public assessment report (AusPar)Daxxify (daxibotulinumtoxinA) is for use in adults for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity and for the treatment of cervical dystonia.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DAXXIFY daxibotulinumtoxinA 100 units powder for injection vial.
-
Prescription medicine registrationActive ingredients: daxibotulinumtoxinA.